当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 现金流量表

华东医药

(000963)

  

流通市值:640.55亿  总市值:641.71亿
流通股本:17.51亿   总股本:17.54亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金33,334,628,825.6321,640,152,875.039,896,088,428.6443,564,701,238.84
收到的税费返还15,628,115.698,235,381.723,909,537.2460,827,371.05
收到其他与经营活动有关的现金566,037,648.66239,783,680.99179,167,865.43544,629,208.52
经营活动现金流入的平衡项目0000
经营活动现金流入小计33,916,294,589.9821,888,171,937.7410,079,165,831.3144,170,157,818.41
购买商品、接受劳务支付的现金21,947,910,270.0813,604,550,741.227,688,555,061.5827,689,294,593.31
支付给职工以及为职工支付的现金3,446,050,305.282,323,118,629.521,232,560,542.553,912,660,863.1
支付的各项税费1,962,213,221.831,477,481,035.41606,028,807.912,612,807,407.43
支付其他与经营活动有关的现金4,053,717,983.882,207,765,050.151,036,544,085.46,026,178,247.87
经营活动现金流出的平衡项目0000
经营活动现金流出小计31,409,891,781.0719,612,915,456.310,563,688,497.4440,240,941,111.71
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,506,402,808.912,275,256,481.44-484,522,666.133,929,216,706.7
二、投资活动产生的现金流量:
收回投资收到的现金1,000,0003,000,0001,000,0002,085,916.63
取得投资收益收到的现金45,200,00027,900,0002,000,00094,516,496.7
处置固定资产、无形资产和其他长期资产收回的现金净额2,528,623.356,946,255.322,328,201.9410,850,236.05
收到的其他与投资活动有关的现金263,981,767.12255,959,940.22-136,030,146.4
投资活动现金流入的平衡项目0000
投资活动现金流入小计312,710,390.47293,806,195.545,328,201.94243,482,795.78
购建固定资产、无形资产和其他长期资产支付的现金930,485,860.82658,042,086.97472,272,778.221,606,618,467.79
投资支付的现金152,360,852.87147,660,247.9965,861,678.42221,474,250
取得子公司及其他营业单位支付的现金348,814,981.61-17,006,187.32162,367,804.5
支付其他与投资活动有关的现金485,504,341.65157,607,933.95157,563,682.873,574,216
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,917,166,036.95963,310,268.91712,704,326.831,994,034,738.29
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,604,455,646.48-669,504,073.37-707,376,124.89-1,750,551,942.51
三、筹资活动产生的现金流量:
吸收投资收到的现金---35,625,300
其中:子公司吸收少数股东投资收到的现金---25,000,000
取得借款收到的现金3,543,115,046.172,552,138,017.631,510,044,486.234,662,018,278.15
收到其他与筹资活动有关的现金343,706,321.33291,490,536.3362,459,038.61401,726,192.5
筹资活动现金流入平衡项目0000
筹资活动现金流入小计3,886,821,367.52,843,628,553.961,572,503,524.845,099,369,770.65
偿还债务支付的现金2,930,078,520.911,988,027,915.091,202,198,901.635,353,842,747.11
分配股利、利润或偿付利息支付的现金1,751,880,188.481,082,542,915.3336,432,249.03613,814,534.49
其中:子公司支付给少数股东的股利、利润5,994,6602,760,660-19,599,647.35
支付其他与筹资活动有关的现金366,279,261.77260,287,332.28262,376,106.69525,073,835.03
筹资活动现金流出平衡项目0000
筹资活动现金流出小计5,048,237,971.163,330,858,162.71,501,007,257.356,492,731,116.63
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,161,416,603.66-487,229,608.7471,496,267.49-1,393,361,345.98
四、汇率变动对现金及现金等价物的影响21,363,561.91-5,787,341.6217,392,454.165,945,890.37
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-238,105,879.321,112,735,457.71-1,103,010,069.37791,249,308.58
加:期初现金及现金等价物余额4,208,160,010.914,208,160,010.914,208,160,010.913,416,910,702.33
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,970,054,131.595,320,895,468.623,105,149,941.544,208,160,010.91
补充资料:
净利润-1,688,215,051.04-2,846,396,949.97
资产减值准备-68,478,748.14-32,283,430.67
固定资产和投资性房地产折旧-274,930,992.33-458,975,090.5
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-274,930,992.33-458,975,090.5
无形资产摊销-149,210,060.05-268,663,850.27
长期待摊费用摊销-4,432,515.07-9,686,575.8
处置固定资产、无形资产和其他长期资产的损失--4,927,280.24--4,319,797.54
固定资产报废损失-567,416.71-5,143,059.9
公允价值变动损失---13,756,372.8
财务费用-54,026,429.63-107,262,813.85
投资损失-23,136,255.81-188,390,620.91
递延所得税--56,325,293.76--52,383,939.15
其中:递延所得税资产减少--47,082,718.43--81,130,329.78
递延所得税负债增加--9,242,575.33-28,746,390.63
存货的减少--723,903,503.56-213,847,980.82
经营性应收项目的减少--1,460,081,003.94--968,973,067.49
经营性应付项目的增加-2,247,011,472.66-685,551,533.53
其他-10,484,621.5-43,012,182.17
现金的期末余额-5,320,895,468.62-4,208,160,010.91
减:现金的期初余额-4,208,160,010.91-3,416,910,702.33
公告日期2024-10-252024-08-162024-04-262024-04-18
审计意见(境内)标准无保留意见
TOP↑